Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:49 AM
Ignite Modification Date:
2025-12-25 @ 2:49 AM
NCT ID:
NCT07180433
Eligibility Criteria:
Inclusion Criteria:
* Inclusion criteria are accepting to undergo 18F-FAPI PET/MRI examinations and
1. diagnosed with local invasive breast cancer,
2. scheduled for neoadjuvant therapy as primary treatment,
3. has recurrent or new breast cancer, or
4. scheduled for neoadjuvant therapy as primary treatment with FDG-PET/CT applied for staging.
Exclusion Criteria:
* other primary malignancies than breast cancer, renal insufficiency or know allergy towards contrast agents, and MR incompatible implants.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT07180433
Study Brief:
Protocol Section:
NCT07180433